Novartis AG (NVSEF) stock
NVSEFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVS
$146.46+2.56 (+1.78%)
Close on Oct 19, 2026Market cap $279.46BP/E 20.5Yield –
Novartis cash
Cash and short-term investments held at the end of each period.
Novartis's cash was $7.62B at Jun 30, 2026. For fiscal 2025 it was $11.44B, down 0.2% from the year before. Over ten years it grew 9.4% a year on average. The highest annual figure on record is $13.39B in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.44B | -0.2% |
| FY2024 | Dec 31, 2024 | $11.46B | -14.4% |
| FY2023 | Dec 31, 2023 | $13.39B | +78.2% |
| FY2022 | Dec 31, 2022 | $7.52B | -39.4% |
| FY2021 | Dec 31, 2021 | $12.41B | +28.5% |
| FY2020 | Dec 31, 2020 | $9.66B | -13.1% |
| FY2019 | Dec 31, 2019 | $11.11B | -16.3% |
| FY2018 | Dec 31, 2018 | $13.27B | +49.8% |
| FY2017 | Dec 31, 2017 | $8.86B | +26.4% |
| FY2016 | Dec 31, 2016 | $7.01B | +49.9% |
| FY2015 | Dec 31, 2015 | $4.67B | -64.1% |
| FY2014 | Dec 31, 2014 | $13.02B | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.62B | +7.8% |
| Q1 FY2026 | Mar 31, 2026 | $6.88B | -40.0% |
| Q4 FY2025 | Dec 31, 2025 | $11.44B | +44.7% |
| Q2 FY2025 | Jun 30, 2025 | $6.66B | -29.7% |
| Q1 FY2025 | Mar 31, 2025 | $7.07B | -47.2% |
| Q4 FY2024 | Dec 31, 2024 | $11.46B | +5.3% |
| Q2 FY2024 | Jun 30, 2024 | $7.90B | -34.1% |
| Q1 FY2024 | Mar 31, 2024 | $9.47B | +26.0% |
| Q4 FY2023 | Dec 31, 2023 | $13.39B | +269.5% |
| Q2 FY2023 | Jun 30, 2023 | $10.89B | -21.4% |
| Q1 FY2023 | Mar 31, 2023 | $12.00B | -3.3% |
| Q4 FY2022 | Dec 31, 2022 | $7.52B | +46.9% |
| Q2 FY2022 | Jun 30, 2022 | $3.63B | -4.6% |
| Q1 FY2022 | Mar 31, 2022 | $13.85B | +43.4% |
| Q4 FY2021 | Dec 31, 2021 | $12.41B | +109.7% |
| Q2 FY2021 | Jun 30, 2021 | $5.12B | +13.0% |
| Q1 FY2021 | Mar 31, 2021 | $3.80B | -65.8% |
| Q4 FY2020 | Dec 31, 2020 | $9.66B | -3.3% |
| Q2 FY2020 | Jun 30, 2020 | $5.92B | -13.1% |
| Q1 FY2020 | Mar 31, 2020 | $4.53B | -65.9% |
| Q4 FY2019 | Dec 31, 2019 | $11.11B | -10.7% |
| Q2 FY2019 | Jun 30, 2019 | $9.99B | +71.9% |
| Q1 FY2019 | Mar 31, 2019 | $6.81B | -23.2% |
| Q4 FY2018 | Dec 31, 2018 | $13.27B | +68.9% |
| Q2 FY2018 | Jun 30, 2018 | $12.45B | +64.4% |
| Q1 FY2018 | Mar 31, 2018 | $5.81B | -17.0% |
| Q4 FY2017 | Dec 31, 2017 | $8.86B | +89.6% |
| Q2 FY2017 | Jun 30, 2017 | $7.86B | -39.7% |
| Q1 FY2017 | Mar 31, 2017 | $7.57B | – |
| Q4 FY2016 | Dec 31, 2016 | $7.01B | – |
| Q4 FY2015 | Dec 31, 2015 | $4.67B | – |
| Q4 FY2014 | Dec 31, 2014 | $13.02B | – |
See a number that looks wrong?